Evidence map›Paper›PMID 37085215›Full record

ReviewClinics in chest medicine2023

What Have We Learned About Transmission of Coronavirus Disease-2019: Implications for Pulmonary Function Testing and Pulmonary Procedures.

David A Kaminsky, Shaikh M Noor Husnain, Danai Khemasuwan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinics in chest medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David A KaminskyPulmonary and Critical Care, University of Vermont Larner College of Medicine, Given D213, 89 Beaumont Avenue, Burlington, VT 05405, USA. Electronic address: david.kaminsky@uvm.edu.
Shaikh M Noor HusnainDepartment of Pulmonary and Critical Care, Section of Interventional Pulmonary, Westchester Medical Center, 100 Woods Road, Valhalla, NY 10595, USA.
Danai KhemasuwanPulmonary and Critical Care, Virginia Commonwealth University Health System, 1200 East Broad Street, Richmond, VA 23298, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of the potential for high aerosol transmission during pulmonary function testing and pulmonary procedures, performing these tests and procedures must be considered carefully during the coronavirus disease-2019 (COVID-19) pandemic. Much has been learned about the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by aerosols and the potential for such transmission through pulmonary function tests and pulmonary procedures, and subsequently preventative practices have been enhanced and developed to reduce the risk of transmission of virus to patients and personnel. This article reviews what is known about the potential for transmission of SARS-CoV-2 during pulmonary function testing and pulmonary procedures and the recommended mitigation steps to prevent the spread of COVID-19.

Indexed as

COVID-19HumansInfectious Disease Transmission, Patient-to-ProfessionalRespiratory Aerosols and DropletsRespiratory Function TestsSARS-CoV-2Aerosol transmissionBronchoscopyCOVID-19Pleural proceduresPulmonary function testingSARS-CoV-2Tracheostomy

Identifiers

PMID37085215
PMCPMC9678821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.